These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 9514046

  • 21. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S, Katoh O, Oguri T, Watanabe H, Yajin K.
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [Abstract] [Full Text] [Related]

  • 22. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U, Walther W, Shoemaker RH.
    J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016
    [Abstract] [Full Text] [Related]

  • 23. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ, Kakehi Y, Yoshida O.
    Int J Urol; 1997 Nov 02; 4(6):583-90. PubMed ID: 9477189
    [Abstract] [Full Text] [Related]

  • 24. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
    Kim WJ, Kakehi Y, Kinoshita H, Arao S, Fukumoto M, Yoshida O.
    J Urol; 1996 Aug 02; 156(2 Pt 1):506-11. PubMed ID: 8683726
    [Abstract] [Full Text] [Related]

  • 25. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
    Stein U, Walther W, Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH.
    J Natl Cancer Inst; 1997 Jun 04; 89(11):807-13. PubMed ID: 9182980
    [Abstract] [Full Text] [Related]

  • 26. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
    Clifford SC, Neal DE, Lunec J.
    Br J Cancer; 1996 Mar 04; 73(5):659-66. PubMed ID: 8605104
    [Abstract] [Full Text] [Related]

  • 27. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD, Doyle LA, Schiffer CA, Lee EJ, Grant CE, Cole SP, Deeley RG, Yang W, Tong Y.
    Leukemia; 1996 Jan 04; 10(1):48-55. PubMed ID: 8558937
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH.
    Oncol Rep; 2009 Jul 04; 22(1):65-71. PubMed ID: 19513506
    [Abstract] [Full Text] [Related]

  • 30. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
    Haga S, Hinoshita E, Ikezaki K, Fukui M, Scheffer GL, Uchiumi T, Kuwano M.
    Jpn J Cancer Res; 2001 Feb 04; 92(2):211-9. PubMed ID: 11223551
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients.
    Gurbuxani S, Singh Arya L, Raina V, Sazawal S, Khattar A, Magrath I, Marie J, Bhargava M.
    Cancer Lett; 2001 Jun 10; 167(1):73-83. PubMed ID: 11323101
    [Abstract] [Full Text] [Related]

  • 34. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI.
    J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R, Versanvoort C, Wright K, Twentyman PR.
    Eur J Cancer; 1996 Nov 01; 32A(12):2136-41. PubMed ID: 9014757
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.